bf/NYSE:ENZ_icon.jpeg

NYSE:ENZ

Enzo Biochem

  • Stock

USD

Last Close

1.15

30/08 20:00

Market Cap

55.57M

Beta: 1.04

Volume Today

11.45K

Avg: 874.22K

PE Ratio

2.37

PFCF: −1.38

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jul '14
Jul '15
Jul '16
Jul '17
Jul '18
Jul '19
Jul '20
Jul '21
Jul '22
Jul '23
revenue
95.95M
-
97.60M
1.72%
102.77M
5.30%
107.80M
4.90%
104.71M
2.87%
81.17M
22.48%
76.02M
6.34%
117.73M
54.87%
107.07M
9.05%
31.06M
70.99%
cost of revenue
54.27M
-
54.77M
0.93%
57.19M
4.41%
59.48M
4.00%
60.38M
1.52%
57.92M
4.08%
52.25M
9.79%
64.15M
22.78%
65.10M
1.48%
19.50M
70.06%
gross profit
41.68M
-
42.83M
2.75%
45.58M
6.44%
48.33M
6.02%
44.33M
8.27%
23.25M
47.55%
23.77M
2.25%
53.58M
125.40%
41.97M
21.67%
11.57M
72.44%
selling and marketing expenses
374K
-
437K
16.84%
400K
8.47%
577K
44.25%
345K
40.21%
general and administrative expenses
41.80M
-
41.07M
1.75%
43.59M
6.13%
44.01M
0.97%
44.47M
1.03%
44.27M
0.45%
49.69M
12.25%
44.91M
9.63%
53.71M
19.60%
27.20M
49.35%
selling general and administrative expenses
41.80M
-
41.07M
1.75%
43.59M
6.13%
44.01M
0.97%
44.47M
1.03%
44.27M
0.45%
42.96M
2.95%
44.91M
4.53%
53.71M
19.60%
27.20M
49.35%
research and development expenses
3.14M
-
3.35M
6.65%
3.52M
5.19%
2.93M
16.91%
3.21M
9.63%
3.17M
1.09%
4.45M
40.09%
3.25M
26.89%
3.77M
15.84%
3.90M
3.64%
other expenses
194K
-
95K
51.03%
122K
28.42%
125K
2.46%
168K
34.40%
382K
127.38%
488K
27.75%
6.91M
1,314.96%
-1.19M
117.25%
380K
131.91%
cost and expenses
102.27M
-
101.47M
0.78%
106.64M
5.09%
109.19M
2.40%
111.75M
2.34%
105.36M
5.72%
99.66M
5.41%
112.31M
12.70%
122.58M
9.14%
50.60M
58.72%
operating expenses
48.01M
-
46.70M
2.71%
49.45M
5.87%
49.71M
0.54%
51.37M
3.32%
47.44M
7.64%
47.41M
0.07%
48.16M
1.58%
57.47M
19.35%
31.11M
45.88%
interest expense
7.14M
-
-3.32M
146.44%
-100.77M
2,937.07%
2.58M
102.56%
9.78M
279.33%
159K
-
ebitda
1.21M
-
-1.82M
250.50%
102.77M
5,743.77%
107.80M
4.90%
104.71M
2.87%
81.17M
22.48%
-15.03M
118.52%
12.53M
183.35%
-10.96M
187.45%
-12.12M
10.59%
operating income
-10.18M
-
-1.21M
88.15%
47.00M
3,997.43%
-3.07M
106.52%
-12.16M
296.74%
78.13M
742.34%
-23.64M
130.25%
9.88M
141.79%
-15.51M
256.99%
-24.74M
59.52%
depreciation and amortization
3.97M
-
3.79M
4.58%
3.84M
1.35%
3.60M
6.30%
3.13M
13.01%
3.04M
3.00%
8.60M
183.40%
2.65M
69.17%
4.55M
71.47%
2.68M
41.04%
total other income expenses net
-3.37M
-
1.83M
154.26%
50.51M
2,661.84%
-1.42M
102.81%
-5.23M
268.85%
-75.64M
1,345.26%
-4.88M
93.55%
-2.00M
58.97%
-2.75M
37.49%
-4.36M
58.32%
income before tax
-9.90M
-
-2.29M
76.86%
46.52M
2,129.45%
-2.42M
105.21%
-11.42M
371.43%
2.49M
121.80%
-28.52M
1,245.84%
7.88M
127.61%
-18.26M
331.89%
-25.02M
37.02%
income tax expense
72K
-
-7K
109.72%
1.23M
17,657.14%
82K
93.33%
-1.10M
1,437.80%
101.27M
9,331.54%
5.37M
94.70%
4.45M
17.13%
4.32M
2.99%
12.30M
184.90%
net income
-9.98M
-
-2.29M
77.10%
45.29M
2,081.88%
-2.50M
105.53%
-10.32M
312.18%
-98.78M
857.09%
-33.89M
65.69%
3.42M
110.11%
-22.58M
759.21%
20.29M
189.86%
weighted average shs out
42.56M
-
45.35M
6.56%
46.15M
1.76%
46.35M
0.43%
46.91M
1.22%
47.35M
0.93%
47.70M
0.73%
48.19M
1.04%
48.59M
0.84%
49.16M
1.16%
weighted average shs out dil
42.56M
-
45.35M
6.56%
46.60M
2.75%
46.35M
0.54%
46.97M
1.34%
47.48M
1.07%
47.70M
0.46%
48.33M
1.32%
48.59M
0.56%
49.16M
1.16%
eps
-0.23
-
-0.05
78.09%
0.98
2,044.44%
-0.05
105.51%
-0.22
307.41%
-2.09
850%
-0.71
66.03%
0.07
110.01%
-0.46
746.98%
-1.27
176.09%
epsdiluted
-0.23
-
-0.05
78.09%
0.97
2,024.60%
-0.05
105.57%
-0.22
307.41%
-2.08
845.45%
-0.71
65.87%
0.07
109.99%
-0.46
748.80%
-1.27
176.09%

All numbers in USD (except ratios and percentages)